TESTING in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said.
This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative.
Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year.
But hopes have been stirred with the success of mRNA technology, which allowed for the development of Covid-19 vaccines in record time, including one from Moderna.
The goal of the vaccine now being tested is to stimulate production of a kind of antibody called "broadly neutralizing antibodies," or bnAbs, which can act against the many variants of HIV that are circulating today.
The vaccine is supposed to teach B lymphocytes, which are part of the immune system, to generate these antibodies.
In this trial, participants are injected with an immunogen -- a substance that can trigger an immune response -- and then a booster immunogen later.
These substances will be delivered with mRNA technology.
"The induction of bnAbs is widely considered to be a goal of HIV vaccination, and this is the first step in that process," Moderna and the IAVI, a research organization, said in a statement.
"Further immunogens will be needed to guide the immune system on this path, but this prime-boost combination could be the first key element of an eventual HIV immunization regimen," said David Diemert, a lead investigator at one of the four sites where the trial is being carried out, George Washington University in the US capital.
The immunogens used in this trial were developed by IAVI and the Scripps Research Institute, with support from the Bill & Melinda Gates Foundation, the US National Institute of Allergy and Infectious Diseases and Moderna.
A first trial last year tested the first immunogen but without employing mRNA technology. It showed that the desired immune response was triggered in dozens of people taking part in the research.
The next step was to bring in Moderna with its new mRNA technique.
"Given the speed with which mRNA vaccines can be produced, this platform offers a more nimble and responsive approach to vaccine design and testing," the Moderna-IAVI statement said.
"The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine," said Mark Feinberg, the CEO of IAVI.
ETX Studio
Mon Jan 31 2022
![Tests of HIV vaccine using mRNA technology have begun Tests of HIV vaccine using mRNA technology have begun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-01/61643593201_VACCINE.jpg)
Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year. - ETX Studio
![Harga petrol, diesel kekal hingga 24 Julai Harga petrol, diesel kekal hingga 24 Julai](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-06/61717993469_RON.jpg)
Harga petrol, diesel kekal hingga 24 Julai
Kementerian Kewangan dalam kenyataan hari ini memaklumkan harga runcit diesel di Sabah, Sarawak dan Labuan kekal pada paras RM2.15 seliter.
![Ladang kelapa sawit dipercayai lokasi Nur Farah Kartini dibunuh - Polis Ladang kelapa sawit dipercayai lokasi Nur Farah Kartini dibunuh - Polis](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51721210176_TBFARAHMAYAT.jpg)
Ladang kelapa sawit dipercayai lokasi Nur Farah Kartini dibunuh - Polis
Polis percaya kawasan ladang kelapa sawit di Kampung Sri Kledang di sini adalah lokasi Nur Farah Kartini Abdullah, dipercayai dibunuh.
Pantau Agenda Reformasi: Bola sepak Malaysia selepas Kim Pan Gon
Niaga AWANI: BSKL dijangka melepasi 1,700 mata pada akhir 2024
Bursa Malaysia dijangka mencatatkan aliran meningkat dengan indeks utama FBM KLCI dijangka melepasi paras 1,700 mata menjelang akhir tahun ini.
Niaga AWANI: Harga emas rekod paras tertinggi dalam sejarah
Harga emas dilaporkan naik ke paras tertinggi dalam sejarah hari ini. Ia berikutan kenyataan terbaharu daripada pegawai Rizab Persekutuan (FED) Amerika Syarikat yang meningkatkan jangkaan bahawa akan berlaku penurunan kadar faedah pada September.
Suspek masih belum digantung tugas
Polis Perak sedang menunggu hasil siasatan terhadap suspek sebelum tindakan menggantung tugas sebagai anggota polis.
Dasar digital perlu pastikan jurang antara miskin dan kaya tidak terus melebar
Datuk Seri Anwar Ibrahim berkata, beliau bukan mahu bersikap negatif terhadap golongan elit, namun menegaskan bahwa sekiranya tidak dikawal, kesenjangan di antara kaya dan miskin akan terus melebar.
Ahli Dewan Rakyat wajib jalani pemeriksaan kesihatan
Semua Ahli Dewan Rakyat diwajibkan untuk menjalani pemeriksaan kesihatan selewat-lewatnya pada 11 November depan.
![Jenazah Nur Farah Kartini dijangka dituntut selepas DNA ibu diambil - Abang Jenazah Nur Farah Kartini dijangka dituntut selepas DNA ibu diambil - Abang](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721206884_NurFarahKartini.jpg)
Jenazah Nur Farah Kartini dijangka dituntut selepas DNA ibu diambil - Abang
Urusan tuntutan jenazah mangsa bunuh Nur Farah Kartini Abdullah dijangka hanya dapat dilakukan selepas pengambilan sampel DNA ibunya di Hospital Kuala Kubu Bharu hari ini.
![[KOLUMNIS] Konotasi 'Belanda' dalam pantun dan peribahasa Melayu [KOLUMNIS] Konotasi 'Belanda' dalam pantun dan peribahasa Melayu](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51721207677_belanda.jpg)
[KOLUMNIS] Konotasi 'Belanda' dalam pantun dan peribahasa Melayu
Pantun merupakan akal budi orang Melayu, iaitu penciptaan bait-bait diksi yang indah yang mempunyai unsur alam dan persekitaran masyarakat.
![AS mulakan ujian klinikal vaksin influenza universal mRNA AS mulakan ujian klinikal vaksin influenza universal mRNA](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-12/81608631351_Vaccine.jpg)
AS mulakan ujian klinikal vaksin influenza universal mRNA
Ujian dimulai dengan pendaftaran sukarelawan di Duke University di Durham, North Carolina.
![ALPS, pusat rawatan kanser Sabah bakal jalin kerjasama strategik teknologi mRNA ALPS, pusat rawatan kanser Sabah bakal jalin kerjasama strategik teknologi mRNA](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-08/61660257807_TBTunJuharMahiruddi.jpg)
ALPS, pusat rawatan kanser Sabah bakal jalin kerjasama strategik teknologi mRNA
ALPS menyediakan perkhidmatan teknologi mRNA dan mencipta rekod memberangsangkan dalam bidang perubatan kanser.
![Pfizer, BioNTech mohon kebenaran FDA untuk dos penggalak kedua Pfizer, BioNTech mohon kebenaran FDA untuk dos penggalak kedua](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-03/81616716267_vaccine.jpg)
Pfizer, BioNTech mohon kebenaran FDA untuk dos penggalak kedua
FDA berkata ia akan menyemak permintaan Pfizer dan BioNTech "secepat mungkin menggunakan pendekatan menyeluruh dan berasaskan sains."
![PICKids: Sasar 70 peratus kanak-kanak divaksin pada Februari PICKids: Sasar 70 peratus kanak-kanak divaksin pada Februari](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-02/41643865616_PICKids.jpg)
PICKids: Sasar 70 peratus kanak-kanak divaksin pada Februari
Sasaran itu dibuat berlandaskan keyakinan disuarakan Pengerusi Jawatankuasa Bertindak Imunisasi COVID-19 Kanak-Kanak (CITF-C), Datuk Dr Noor Azmi Ghazali.
![Hanya 25 kes miokarditis dikesan selepas terima vaksin - KP Kesihatan Hanya 25 kes miokarditis dikesan selepas terima vaksin - KP Kesihatan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-01/61641628505_NoorHisham.jpg)
Hanya 25 kes miokarditis dikesan selepas terima vaksin - KP Kesihatan
Hanya 25 kejadian kes radang otot jantung atau miokarditis dikesan dalam tempoh 21 hari selepas individu menerima vaksinasi COVID-19.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-11/71638189911_BAP.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![MOSTI jalin kerjasama negara luar percepat proses pembangunan vaksin - Dr Adham MOSTI jalin kerjasama negara luar percepat proses pembangunan vaksin - Dr Adham](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-07/71625920971_AdhamBaba.jpg)
MOSTI jalin kerjasama negara luar percepat proses pembangunan vaksin - Dr Adham
Dr Adham Baba berkata perkara tersebut akan diperincikan dalam pelan tindakan yang bakal dilancarkan tidak berapa lama lagi.
![Vaksin berasaskan protein keluaran India dapat kelulusan ujian klinikal ke atas manusia Vaksin berasaskan protein keluaran India dapat kelulusan ujian klinikal ke atas manusia](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-08/81630083098_vaksin.jpg)
Vaksin berasaskan protein keluaran India dapat kelulusan ujian klinikal ke atas manusia
Kelulusan diberi selepas Subject Expert Committee (SEC) meneliti permohonan tersebut dalam satu mesyuarat.
![COVID-19: Moderna sedia untuk dapat kelulusan penuh FDA COVID-19: Moderna sedia untuk dapat kelulusan penuh FDA](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-08/51628157125_moderna.jpg)
COVID-19: Moderna sedia untuk dapat kelulusan penuh FDA
Menurut syarikat pengeluar vaksin COVID-19 itu, ia melibatkan kelulusan penuh bagi individu berusia 18 tahun dan ke atas.
![Thailand jangka hasilkan vaksin COVID-19 tempatan menjelang akhir tahun Thailand jangka hasilkan vaksin COVID-19 tempatan menjelang akhir tahun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-07/61627624872_Vaksinator.jpg)
Thailand jangka hasilkan vaksin COVID-19 tempatan menjelang akhir tahun
Vaksin tempatan RNA messenger (mRNA) COVID-19 Thailand dikenali ChulaCov19 dijangka tersedia pada akhir tahun ini atau awal tahun depan.